Medicine composition for treating alzheimer disease and preparation method of medicine composition

A technology of Alzheimer's disease and composition, which is applied in the field of medicine, can solve problems such as side effects and impact on patients' physical and mental health, and achieve the effects of improving symptoms, better drug treatment effect, and delaying development
CN105288136AInactive Publication Date: 2016-02-03QINGDAO MERRITT MEDICAL TECH CO LTD
8 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Patent Type
Applications(China)
Current Assignee / Owner
QINGDAO MERRITT MEDICAL TECH CO LTD
Publication Date
2016-02-03
Estimated Expiration
Not applicable Β· inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the field of traditional Chinese medicines, relates to a medicine composition for treating the alzheimer disease and a preparation method of the medicine composition. Aiming at insufficiency of the conventional chemical treatment medicines for the alzheimer disease, the traditional Chinese medicine composition for treating or preventing the alzheimer disease is provided. The medicine composition comprises the following components: 10-50 parts of fig, 10-20 parts of ophiopogon japonicus, 5-20 parts of dioscorea opposita Thunb, 5-15 parts of rheum officinale, 5-10 parts of szechwan Chinaberry fruit, 5-15 parts of a cissus kerrii extract, 5-15 parts of tuber fleeceflower stem, 1-10 parts of roasted radix polygoni multiflori, 5-15 parts of spreading hedyotis herb, 9-15 parts of cistanche, 9-15 parts of ligusticum wallichii, 5-15 parts of radix dipsaci, 0.2-9 parts of herba schizonepetae, 5.5-15 parts of epimedium, 6-9 parts of acanthopanax root and 10-15 parts of panax notoginseng. The traditional Chinese medicine composition has the excellent treatment effect in the aspect of treating the alzheimer disease, is low in medicine side effect, and has a remarkable clinical popularization value.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical composition for treating Alzheimer's disease and a preparation method thereof. Background technique

[0002] Dementia refers to mental decline caused by psychogenic (such as praecox) or by diseases that damage brain matter (such as neurosyphilis or arteriosclerosis). Decline is the main clinical feature, including the decline of memory, thinking, comprehension, judgment, calculation and other functions and varying degrees of personality changes. Generally, there is no disturbance of consciousness. Dementia can occur in people of all ages, but is most common in the elderly.

[0003] Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive development. Clinically, it is characterized by comprehensive dementia such as memory impairment, aphasia, apraxia, agnosia, impairment of visuospatial skills, executive dysfunction, and p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More